MDNA Company Profile and Key Details

Q: Who are the executives of MDNA?

Dr. Fahar Merchant Ph.D.Founder, Chairman, Pres & Chief Executive OfficerMs. Rosemina Merchant B.Sc., M.E.ScFounder, Chief Devel. Officer & DirectorMs. Elizabeth Williams C.A., CPA, CA, CPAChief Financial Officer & Corporation Sec.Dr. Martin Bexon M.D., MBBSActing Chief Medical Officer & Head of Clinical Devel.

NASDAQ : MDNA

Medicenna Therapeutics

$0.16

At Close 4:00 PM

Not Actively Trading

61.37

BESG ScoreESG Rating

Profile Key Stats Analyst Ratings Ownership Ratios Financials Dividend & splits Sentiment Forecast

Price Chart

Stock Price Today

Medicenna Therapeutics Corp. (MDNA) stock remained unchanged at $0.16 a share on NASDAQ. The stock opened at $0.20, fluctuating between $0.15 to $0.20 during the session.

Stock Snapshot

0.157

Prev. Close

Market Cap

0.15125

Day Low

-1.7444444444444445

P/E Ratio

-0.09

EPS (TTM)

-0.19

Cash Flow per Share

0.2

Open

Number of Shares

0.1999

Day High

70.02%

Free Float in %

0.34

Book Value

1.26M

Volume

Relevant Articles

SEC Fillings

Current Report (8-k)

Filing Date	Accepted Date

Annual Report (10-k)

Filing Date	Accepted Date

Stock Price History Chart

Date	Open	High	Low	Close	Volume
Jan 16, 2025	0.20	0.20	0.15	0.16	1.26M
Nov 27, 2023	0.37	0.37	0.34	0.37	52.37K
Nov 24, 2023	0.33	0.34	0.32	0.34	91.44K
Nov 22, 2023	0.31	0.32	0.31	0.31	2.98K
Nov 21, 2023	0.31	0.34	0.31	0.32	28.76K
Nov 20, 2023	0.32	0.34	0.31	0.31	29.05K
Nov 17, 2023	0.36	0.37	0.30	0.32	77.44K
Nov 16, 2023	0.37	0.38	0.36	0.36	132.53K
Nov 15, 2023	0.40	0.40	0.37	0.38	261.2K
Nov 14, 2023	0.39	0.40	0.37	0.37	65.07K
Nov 13, 2023	0.39	0.39	0.34	0.37	36.4K
Nov 10, 2023	0.39	0.44	0.33	0.44	254.84K
Nov 09, 2023	0.35	0.40	0.35	0.39	165.34K
Nov 08, 2023	0.33	0.36	0.30	0.34	283.9K
Nov 07, 2023	0.30	0.35	0.29	0.33	351.42K
Nov 06, 2023	0.28	0.35	0.22	0.32	811.09K
Nov 03, 2023	0.18	0.26	0.18	0.26	248.66K
Nov 02, 2023	0.16	0.19	0.16	0.18	189.01K
Nov 01, 2023	0.20	0.20	0.15	0.16	1.27M
Oct 31, 2023	0.18	0.21	0.17	0.18	452.26K

Contact Details

Toronto, ON M4W 3E2

Canada

https://www.medicenna.com 416 648 5555

About Company

Medicenna Therapeutics Corp. is an immunotherapy company dedicated to discovering and commercializing innovative Superkines and "empowered Superkines" for the treatment of various cancers and other ailments. The company's primary therapeutic candidate, MDNA55 (an interleukin-4 (IL-4) EC), has successfully completed a Phase IIb clinical trial for recurrent glioblastoma. This product is also in earlier preclinical and clinical development stages for other brain and non-brain tumors. Medicenna's pipeline also features several other promising compounds: MDNA11: An enhanced version of IL-2, engineered to activate and proliferate the immune cells essential for fighting cancer. MDNA209: An IL-2 antagonist aimed at treating autoimmune conditions such as multiple sclerosis and graft-versus-host disease. MDNA413: A dual IL-4/IL-13 antagonist being developed for cancer immunotherapies. MDNA132: An IL-13 Superkine currently in development for solid tumors. Additionally, the company utilizes its proprietary BiSKITs platform, an advanced technology designed to create custom Superkines by fusing them with other proteins, antibodies, cytokines, or Superkines. Medicenna Therapeutics Corp. is headquartered in Toronto, Canada.

Stock Peers

ARGX

-4.76-0.47%

argenx SE$1,002.31 REGN

-2.66-0.33%

Regeneron Pharmaceuticals, Inc.$807.65 MDGL

12.5+2.34%

Madrigal Pharmaceuticals, Inc.$546.66 VRTX

-7.78-1.47%

Vertex Pharmaceuticals Incorporated$521.12 UTHR

8.85+1.78%

United Therapeutics Corporation$506.82 ONC

-0.48-0.14%

BeOne Medicines AG$351.00 KRYS

-3.17-0.90%

Krystal Biotech, Inc.$348.09 PRAX

-7.18-2.04%

Praxis Precision Medicines, Inc.$345.30 KRTX

0.09+0.03%

Karuna Therapeutics, Inc.$329.83 LGND

-0.78-0.27%

Ligand Pharmaceuticals Incorporated$288.05

Frequently Asked Questions

What is the current Medicenna Therapeutics Corp. (MDNA) stock price?

Medicenna Therapeutics Corp. (NASDAQ: MDNA) stock price is $0.16 in the last trading session. During the trading session, MDNA stock reached the peak price of $0.20 while $0.15 was the lowest point it dropped to. The percentage change in MDNA stock occurred in the recent session was 0% while the dollar amount for the price change in MDNA stock was $0.00.

MDNA's industry and sector of operation?

The NASDAQ listed MDNA is part of Biotechnology industry that operates in the broader Healthcare sector. Medicenna Therapeutics Corp. designs, manufactures, and markets smartphones, personal computers, tablets, wearables, and accessories worldwide.

Who are the executives of MDNA?

Dr. Fahar Merchant Ph.D.
Founder, Chairman, Pres & Chief Executive Officer
Ms. Rosemina Merchant B.Sc., M.E.Sc
Founder, Chief Devel. Officer & Director
Ms. Elizabeth Williams C.A., CPA, CA, CPA
Chief Financial Officer & Corporation Sec.
Dr. Martin Bexon M.D., MBBS
Acting Chief Medical Officer & Head of Clinical Devel.

How MDNA did perform over past 52-week?

MDNA's closing price is 3.8% higher than its 52-week low of $0.15 where as its distance from 52-week high of $0.20 is -21.46%.

How many employees does MDNA have?

Number of MDNA employees currently stands at 16.

Link for MDNA official website?

Official Website of MDNA is: https://www.medicenna.com

How do I contact MDNA?

MDNA could be contacted at phone 416 648 5555 and can also be accessed through its website. MDNA operates from 2 Bloor Street West, Toronto, ON M4W 3E2, Canada.

How many shares of MDNA are traded daily?

MDNA stock volume for the day was 1.26M shares. The average number of MDNA shares traded daily for last 3 months was 1.26M.

What is the market cap of MDNA currently?

The market value of MDNA currently stands at $0.00 with its latest stock price at $0.16 and 0 of its shares outstanding.

Stocks Telegraph provides information and tools designed to assist investors and Wall Street players. A major goal is to offer financiers comprehensive information that will help them gain insight into investing.

Stocks Telegraph does not provide any advice or recommendations for buying or selling stocks, securities, or other financial products. Information contained on this website is for informational purposes only and should not be construed as professional financial, investment or other advice. Stocks Telegraph is not liable for any loss or damage that may occur as a result of reliance on this data.

Employees	16
Beta	0.77
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Biotechnology

Employees	16
Beta	0.77
Sales or Revenue	$0.00
5Y Sales Change%	0%
Fiscal Year Ends	March
Sector	Healthcare
Industry	Biotechnology

MDNA Company Profile and Key Details

Medicenna Therapeutics

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Frequently Asked Questions

Price Chart

Stock Price Today

Stock Snapshot

Relevant Articles

SEC Fillings

Current Report (8-k)

Annual Report (10-k)

Stock Price History Chart

Contact Details

About Company

Company Information

Stock Peers

Company Overview

Valuation Metrics

Dividend & Fair Value

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Price Forecast & Outlook

Key Takeaways

Frequently Asked Questions

Company Overview

Earnings & Analyst Outlook

Financial & Profitability Overview

Quarterly Financial Highlights

Dividend & Fair Value

Price Forecast & Outlook

Key Takeaways

Valuation Metrics